本页面由Tiger Trade Technology Pte. Ltd.提供服务

Taysha Gene Therapies, Inc.

4.14
-0.3500-7.80%
成交量:421.42万
成交额:1,783.06万
市值:13.49亿
市盈率:-10.03
高:4.56
开:4.46
低:4.13
收:4.49
52周最高:7.30
52周最低:3.69
股本:3.26亿
流通股本:2.33亿
量比:0.92
换手率:1.81%
股息:- -
股息率:- -
每股收益(TTM):-0.4126
每股收益(LYR):-0.3409
净资产收益率:-47.05%
总资产收益率:-23.82%
市净率:3.48
市盈率(LYR):-12.14

数据加载中...

2024/11/13

重要事件披露

Form 8-K - Current report
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/18

重要事件披露

Form 8-K - Current report
2024/05/30

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

重要事件披露

Form 8-K - Current report